Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
FibroBiologics, Inc. Common Stock
Market Cap
$2.47M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$2.38M
Operating Margin
-991.71%
TTM Avg
-581.79%
3Y Avg
-302.08%
5Y Avg
-237.73%
Market Cap
$2.37M
Operating Margin
-102380.23%
TTM Avg
-77298.57%
3Y Avg
-57151.39%
5Y Avg
-38807.57%
Market Cap
$2.36M
Operating Margin
-869.34%
TTM Avg
-752.59%
3Y Avg
-4678.16%
5Y Avg
-3954.97%
Market Cap
$2.59M
Operating Margin
-171.58%
TTM Avg
-133.61%
3Y Avg
-21023.40%
5Y Avg
-14015.60%
Market Cap
$2.64M
Operating Margin
-465.42%
TTM Avg
-301.21%
3Y Avg
-203.21%
5Y Avg
-149.24%
Market Cap
$2.05M
Operating Margin
-391.87%
TTM Avg
-327.81%
3Y Avg
-323.70%
5Y Avg
-419.63%
Market Cap
$1.92M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.09M
Operating Margin
-4350.05%
TTM Avg
-3615.82%
3Y Avg
-8354.24%
5Y Avg
-15697.02%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| FibroBiologics, Inc. Common Stock (FBLG) | $2.47M | 0.00% | 0.00% | 0.00% | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $2.38M | -991.71% | -581.79% | -302.08% | -237.73% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.37M | -102380.23% | -77298.57% | -57151.39% | -38807.57% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.36M | -869.34% | -752.59% | -4678.16% | -3954.97% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.59M | -171.58% | -133.61% | -21023.40% | -14015.60% |
| iSpecimen Inc. (ISPC)vs › | $2.64M | -465.42% | -301.21% | -203.21% | -149.24% |
| Jaguar Health, Inc. (JAGX)vs › | $2.05M | -391.87% | -327.81% | -323.70% | -419.63% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.09M | -4350.05% | -3615.82% | -8354.24% | -15697.02% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.13M | 0.00% | -11613.39% | -11298.29% | -8806.57% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
